Last reviewed · How we verify

NCT03623880

Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders

Completed NA Last updated 30 March 2023
What this trial tests

NA trial testing Unified Protocol in Pelvic Floor Disorders in 38 participants. Completed in 10 December 2020.

Timeline
3 September 2018
Primary endpoint
10 December 2020
10 December 2020

Quick facts

Lead sponsorNorthwestern University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment38
Start date3 September 2018
Primary completion10 December 2020
Estimated completion10 December 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Northwestern University

Who can join

18 and older, female only, with Pelvic Floor Disorders or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this proposal is to test a novel behavioral treatment - Unified Protocol Cognitive-Behavior Therapy (UP-CBT)1 - to enhance quality of life in women with pelvic floor disorders. Emotional distress is treatable using behavioral procedures, and effective treatment would increase women's emotional health and help to reduce urinary symptoms (e.g., incontinence, frequent urination). Women with pelvic floor disorders are often seen in the urogynecology clinic, which makes this setting ideal for offering additional interventions that may improve their quality of life. Unfortunately, many women with pelvic floor disorders may not receive effective behavioral treatment, such as cognitive behavior therapy, because urogynecologists and other medical professionals may not be aware of providers in their community who offer this treatment. The investigators will enhance treatment options by 1) providing evidence for an all-purpose cognitive-behavioral intervention (i.e., UP-CBT), 2) offering treatment in the urogynecology clinic, maximizing convenience, and 3) improving clinical outcomes for these patients. Specific Aims: 1. To demonstrate that UP-CBT is an effective form of therapy for women with lower urinary tract symptoms. 2. To use baseline characteristics in moderation analyses to determine which women will be most likely to have a good response to therapy. 3. To use mediation analyses to test a possible causal chain of events - Does treatment lead to lower anxiety, which in turn leads to fewer urinary symptoms?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Enhancing behavioral treatment for women with pelvic floor disorders: Study protocol for a pilot randomized controlled trial.
    Taple BJ, Griffith JW, Weaver C, Kenton KS. · · 2020 · cited 3× · PMID 31956723 · DOI 10.1016/j.conctc.2019.100514

Verify or expand the search:

Other trials of Unified Protocol

Trials testing the same drug.

Other recruiting trials for Pelvic Floor Disorders

Currently open trials in the same condition.

Other Northwestern University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03623880.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing